Content area
Full text
To decide whether a new treatment should be used, statistical significance of its effectiveness over current treatment alone is insufficient. Measures of the size of the treatment effects (that is, clinical significance) are also necessary. 1
Statistical significance measures how likely that any apparent differences in outcome between treatment and control groups are real and not due to chance. p Values and confidence intervals (CI) are the most commonly used measures of statistical significance. The p values give the probability that any particular outcome would have arisen by chance with the assumption that the new and the control treatments are equally effective as the null hypothesis. CI estimate the range within which the real results would fall if the trial is conducted many times. Hence, 95% CI of the difference in treatment outcomes between the two groups would indicate the range which the differences between the two treatments would fall on 95% of the occasions, if the trial is carried out many times. 2
Clinical significance measures how large the differences in treatment effects are in clinical practice. Different measures have been devised. Relative risk is independent of the prevalence of the disease and can be applied to populations with different prevalence of the disease. Relative risk is the ratio of the risks in the treatment group to the event rate in the control group. However, patients may not consider this measure relevant to them as it does not specify the size of the absolute risk. The measures absolute risk reduction (ARR) and numbers needed to treat (NNT) vary with the prevalence of the disease. ARR is simply the difference in the absolute risks between the treatment group and the control group. NNT is the number of patients needed to treat to prevent one adverse event, and is numerically equal to 1/ARR. NNT has been highlighted as a meaningful measure of clinical significance. 3 The level of treatment effect regarded as clinically significant also depends on the severity of the disease and any potential side effects of the treatment.
A common measure of combined statistical and clinical significance is to state a measure of clinical significance (for example, relative risk, ARR, or NNT) with its 95% CI. For example, taking into account the prevalence of...